Health Care & Life Sciences » Biotechnology | Anthera Pharmaceuticals Inc.

Anthera Pharmaceuticals Inc. | Ownership

Companies that own Anthera Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Heights Capital Management, Inc.
784,744
3%
784,744
0%
12/31/2017
Anson Advisors, Inc.
625,000
2.39%
0
0.49%
12/31/2017
Wedbush Securities, Inc. (Investment Management)
210,914
0.81%
150,000
0%
06/30/2018
Medical Strategy GmbH
109,500
0.42%
13,000
0.01%
11/30/2017
Sectoral Asset Management, Inc.
17,500
0.07%
0
0%
11/30/2017
Meeder Asset Management, Inc.
9,035
0.04%
1,913
0%
06/29/2018
Invesco Capital Management LLC
4,187
0.02%
0
0%
09/05/2018
KMS Financial Services, Inc.
1,500
0.01%
0
0%
06/30/2018
BlackRock Advisors LLC
690
0%
0
0%
01/31/2018
The Vanguard Group, Inc.
649
0%
0
0%
06/30/2018

About Anthera Pharmaceuticals

View Profile
Address
25801 Industrial Boulevard
Hayward California 94545
United States
Employees -
Website http://www.anthera.com
Updated 07/08/2019
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. It offers Sollpura and blisibimod to treat diseases such as exocrine pancreatic insufficiency and Immunoglobulin A nephropathy. The company was founded by Paul F.